Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: ENOV ) 41.27 -0.79 (-1.88%) Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ENOV < Previous 1 2 3 4 Next > Enovis to Host Third Quarter 2024 Results Conference Call on November 6th October 10, 2024 From Enovis Corporation Via GlobeNewswire Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says October 03, 2024 JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes... Via Benzinga The Latest Analyst Ratings For Enovis October 03, 2024 Via Benzinga Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies September 09, 2024 From Enovis Corporation Via GlobeNewswire Critical Insights From Enovis Analyst Ratings: What You Need To Know July 02, 2024 Via Benzinga A Closer Look at 6 Analyst Recommendations For Enovis May 03, 2024 Via Benzinga Earnings Outlook For Enovis February 21, 2024 Via Benzinga 5 Analysts Have This To Say About Enovis February 13, 2024 Via Benzinga Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting September 05, 2024 With the upcoming launch of the innovative Tarsoplasty solution and live demonstrations of the Better Step patient-focused platform, Enovis™ Foot & Ankle continues to drive its portfolio into “The Fast... From Enovis Corporation Via GlobeNewswire Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures August 20, 2024 First surgeries using EMPOWR Revision Knee™ with EMPOWR™ Cones successfully completed by design consultants Dr. Beau Kildow and Dr. Leonard T. Buller. From Enovis Corporation Via GlobeNewswire Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability August 19, 2024 Revolutionary Scandinavian Total Ankle Replacement (STAR® Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert From Enovis Corporation Via GlobeNewswire Enovis to Participate in Upcoming Investor Conferences August 12, 2024 From Enovis Corporation Via GlobeNewswire ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024 August 07, 2024 ENOV stock results show that Enovis beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Enovis Announces Second Quarter 2024 Results August 07, 2024 From Enovis Corporation Via GlobeNewswire Enovis Announces Time Change for Second Quarter 2024 Results Conference Call July 25, 2024 From Enovis Corporation Via GlobeNewswire Enovis to Host Second Quarter 2024 Results Conference Call on August 7th July 16, 2024 From Enovis Corporation Via GlobeNewswire Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse® July 12, 2024 New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity... From Enovis Corporation Via GlobeNewswire Top 3 Health Care Stocks That Could Blast Off In June June 21, 2024 Via Benzinga 5 Medical Info Systems Stocks To Buy For Stable Returns May 11, 2024 The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. Via Talk Markets Enovis to Participate in Upcoming Investor Conferences May 10, 2024 From Enovis Corporation Via GlobeNewswire Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month May 07, 2024 Via Benzinga ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Enovis Announces First Quarter 2024 Results May 02, 2024 From Enovis Corporation Via GlobeNewswire Enovis to Host First Quarter 2024 Results Conference Call on May 2nd April 17, 2024 From Enovis Corporation Via GlobeNewswire Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference March 28, 2024 From Enovis Corporation Via GlobeNewswire Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact February 22, 2024 Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent... Via Benzinga Topics Earnings Exposures Financial Enovis Announces Fourth Quarter and Full Year 2023 Results February 22, 2024 From Enovis Corporation Via GlobeNewswire Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting February 12, 2024 From Enovis Corporation Via GlobeNewswire Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 February 07, 2024 From Enovis Corporation Via GlobeNewswire Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting January 29, 2024 New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio. From Enovis Corporation Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
